文献
J-GLOBAL ID:202002279981023539
整理番号:20A2544510
未治療の原発性免疫性血小板減少症の子供の第一選択治療である伝統的プレドニソンの代替としての高用量デキサメタゾン:前向き無作為化単一施設研究
High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study
著者 (18件):
Ma Jie
(Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China)
,
Ma Jie
(Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China)
,
Ma Jie
(Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China)
,
Fu Lingling
(Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China)
,
Fu Lingling
(Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China)
,
Fu Lingling
(Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China)
,
Chen Zhengping
(Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China)
,
Chen Zhengping
(Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China)
,
Chen Zhengping
(Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China)
,
Gu Hao
(Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China)
,
Gu Hao
(Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China)
,
Gu Hao
(Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China)
,
Ma Jingyao
(Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China)
,
Ma Jingyao
(Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China)
,
Ma Jingyao
(Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China)
,
Wu Runhui
(Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China)
,
Wu Runhui
(Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China)
,
Wu Runhui
(Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China)
資料名:
International Journal of Hematology
(International Journal of Hematology)
巻:
112
号:
6
ページ:
773-779
発行年:
2020年12月
JST資料番号:
F0888A
ISSN:
0925-5710
CODEN:
IJHEEY
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)